CureVac N.V (CVAC) News

CureVac N.V (CVAC): $4.10

0.08 (-1.91%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

C

Add CVAC to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#26 of 337

in industry

Filter CVAC News Items

CVAC News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

CVAC News Highlights

  • 404 Page not found

    Error: Page not found

    The requested URL was not found on this server.

  • 404 Page not found

    Error: Page not found

    The requested URL was not found on this server.

  • 404 Page not found

    Error: Page not found

    The requested URL was not found on this server.

Latest CVAC News From Around the Web

Below are the latest news stories about CUREVAC NV that investors may wish to consider to help them evaluate CVAC as an investment opportunity.

Moderna stock forfeits gains as first US bird flu death puts vaccine development in focus

The first human bird flu death in the US has Moderna's vaccine development in focus for investors this week.

Yahoo | January 8, 2025

Vaccine Stocks Jump After CDC Reports First US Bird-Flu Death

The first bird-flu fatality in the United States sparks investor interest in several vaccine makers that are developing experimental H5N1 vaccines.

Yahoo | January 8, 2025

Moderna Stock Jumps Amid Bird Flu Vaccine Hope After First U.S. Death

The company is one of a few drugmakers currently developing a vaccine for the illness, which is spreading rapidly through North America.

Yahoo | January 7, 2025

Discover 3 US Penny Stocks With Market Caps Over $200M

As the U.S. stock market experiences a mixed performance, with the Dow Jones Industrial Average gaining for its fifth straight session while other indices falter, investors are exploring diverse opportunities. Penny stocks, often considered speculative investments due to their low price point and smaller market presence, can still offer significant potential when backed by strong financials. In this article, we will explore several penny stocks that stand out for their financial strength and...

Yahoo | December 27, 2024

Cerus And 2 Other US Penny Stocks To Watch

The U.S. stock market recently experienced a stumble, particularly in technology shares, as investors assessed earnings reports and economic data amidst fluctuating interest rates and inflation expectations. In such a climate, the appeal of penny stocks remains significant for those seeking affordable entry points with potential growth prospects. While the term "penny stocks" may seem outdated, these typically smaller or newer companies can offer unique opportunities when supported by strong...

Yahoo | November 28, 2024

Loss-Making CureVac N.V. (NASDAQ:CVAC) Set To Breakeven

CureVac N.V. ( NASDAQ:CVAC ) is possibly approaching a major achievement in its business, so we would like to shine...

Yahoo | November 26, 2024

Is the Options Market Predicting a Spike in CureVac (CVAC) Stock?

Investors need to pay close attention to CureVac (CVAC) stock based on the movements in the options market lately.

Yahoo | November 20, 2024

Is CureVac N.V. (CVAC) the Best German Stock to Buy Now?

We recently compiled a list of the 10 Best German Stocks To Buy Now. In this article, we are going to take a look at where CureVac N.V. (NASDAQ:CVAC) stands against the other German stocks. In Germany, the economic growth is based on industry. According to Deutschland.de, Germany’s manufacturing industry contributed 26.6% to the country’s gross […]

Yahoo | November 19, 2024

Where are they now? 4 biotechs that soared then crashed during the pandemic

How Novavax and others have restructured and trudged forward after their COVID-era high.

Yahoo | November 15, 2024

CureVac NV (CVAC) Q3 2024 Earnings Call Highlights: Strong Financial Performance and Strategic ...

CureVac NV (CVAC) reports robust revenue growth and strategic advancements in oncology, despite ongoing litigation challenges.

Yahoo | November 13, 2024


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!